Sabby Management, LLC Isoray, Inc. Transaction History

Sabby Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 15, 2019	SELL	$0.31 - $0.42 $114,889 - $155,657	-370,612 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$0.37 - $0.47 $336,356 - $427,263	-909,072 Reduced 71.04%	370,612 $152,000
Q1 2019 May 15, 2019	SELL	$0.32 - $0.46 $312,046 - $448,566	-975,145 Reduced 43.25%	1,279,684 $467,000
Q4 2018 Feb 14, 2019	BUY	$0.27 - $0.52 $88,922 - $171,257	329,342 Added 17.1%	2,254,829 $676,000
Q3 2018 Nov 14, 2018	BUY	$0.43 - $1.07 $827,959 - $2.06 Million	1,925,487 New	1,925,487 $999,000

145K

Ticker ISR
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 142,112,992
Market Cap $98.1M
Description
Isoray, Inc., through its subsidiary, IsoRay Medical, Inc., develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and nec...

Get notified when there are updates to the investment portfolio of Sabby Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sabby Management, LLC with notifications on news.